Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2018 13:09 ET | Source: Cannabis Science, Inc.

Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board

IRVINE, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
September 21, 2018 08:23 ET | Source: Cannabis Science, Inc.

Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board

IRVINE, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
September 12, 2018 08:13 ET | Source: Cannabis Science, Inc.

Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards

IRVINE, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
August 31, 2018 12:35 ET | Source: Cannabis Science, Inc.

Cannabis Science Invited to Deliver Keynote Address at European Summit Organized by The University of Heidelberg and Harvard Medical School’s Global Health Catalyst

IRVINE, CA, Aug. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
August 21, 2018 07:48 ET | Source: Cannabis Science, Inc.

CANNABIS SCIENCE TODAY LAUNCHES ITS NEW CORPORATE WEBSITE

IRVINE, CA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the...
August 13, 2018 11:53 ET | Source: Cannabis Science, Inc.

Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements

IRVINE, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce it is in...
August 08, 2018 09:10 ET | Source: Cannabis Science, Inc.

Cannabis Science Celebrates the Lives and Mourns the Loss of Dr. Allen Herman and The Honorable Ronald V. Dellums

IRVINE, CA, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, celebrates the lives of Dr. Allen Herman,...
July 24, 2018 12:05 ET | Source: Cannabis Science, Inc.

Cannabis Science and FSO NAC Sign for New 100-Acre Property in Minden, Nevada as the Industrial Hemp Research Projects in Nevada Continue to Flourish for the Group

IRVINE, CA, July 24, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the signing of...
July 10, 2018 07:35 ET | Source: Cannabis Science, Inc.

Cannabis Science Research Group FSO NAC / HRM Farms Receives Approvals From the Nevada Department of Agriculture for its Newest 40-Acre Industrial Hemp Research Project in Nevada

IRVINE, CA, July 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the immediate...
July 09, 2018 08:43 ET | Source: Cannabis Science, Inc.

Cannabis Science, Harvard Medical School’s Global Health Catalyst, Elpasso Farms (South Africa), and American States University Partner to Strengthen Africa’s Economic and Healthcare Infrastructure

IRVINE, CA, July 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce Harvard...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right